Followers | 14 |
Posts | 1963 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |

Friday, June 28, 2024 12:22:59 PM
not unreasonable to accuse management of theft
Recent KPTI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:13:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:52:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:51:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:49:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 09:46:17 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/03/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2025 09:16:55 PM
- Karyopharm Announces 1-for-15 Reverse Stock Split • PR Newswire (US) • 02/24/2025 01:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 12:32:17 PM
- Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress • PR Newswire (US) • 02/19/2025 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2025 02:36:58 PM
- Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 • PR Newswire (US) • 02/12/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2025 09:16:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2025 09:15:35 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 02/03/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 09:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 09:06:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:34:48 PM
- Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives • PR Newswire (US) • 01/13/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 09:03:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2025 10:07:56 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 01/02/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 12:08:18 PM
FEATURED LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates • Mar 21, 2025 9:40 AM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM
VAYK Forms Partnership with Airbnb Investing Group to Offer Service Solution • VAYK • Mar 20, 2025 9:00 AM
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger • CATV • Mar 20, 2025 8:30 AM
NUBURU Announces Elimination of 100% of its Long-Term Indebtedness and $5.15 Million Strategic Investment in Supply@ME Capital • BURU • Mar 19, 2025 8:53 AM